Planters adds four new ways for consumers to harness the ‘Power of the Peanut’
NORTHFIELD, Ill. — Planters, a brand from Kraft Foods Group, introduced four new peanut flavors to its product lineup. Consumers can now choose from Salted Caramel, Cocoa, Chipotle and Smoked flavors.
The brand incorporated both culinary trends and fan feedback when developing the new varieties, which pack up to 7 g of protein and at least four essential nutrients per serving.
"These delicious flavors are unlike anything Planters has developed for peanuts before," said Peter Cotter, brand manager for Planters. "While the new 6-oz. containers are the perfect size for sharing, we won’t judge snackers for wanting to keep them in their own snack drawers."
The new Planters peanut flavors are available nationwide in the snack aisle of grocery stores and carry a suggested retail price of $1.99 for each 6-oz. container.
Litte Seashell announces summer collection
TORONTO — Little Seashell, a Canada-based designer and manufacturer of greeting cards, announced its summer 2014 collection, which includes three vibrant designs.
The cards, which includes motifs like a London phone booth, a vintage sewing machine and flowers with a newspaper background, are embellished with a touch of glitter and rhinestones. Card sizes are 6-in. by 4.5-in. folded, and are printed on 12-pt cardstock. The suggested retail price is $4.75. The complete line of cards can be viewed at LittleSeashellCards.com
Greer Labs launches Oralair
LENOIR, N.C. — Greer Labs announced the launch and commmercial availability of Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablets. The drug is used for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis.
“We are pleased to now be able to supply Oralair, which provides an additional option for treating grass allergies in the United States and helps to fill a current unmet need in allergy patient care,” said John G. Roby, Greer president and CEO. “Grass allergies affect millions of people, however we know that many patients who are candidates for immunotherapy refuse or discontinue allergy injections. Greer’s commitment to allergy innovation is guided by our desire to provide support to allergy specialists and relief to patients through immunotherapy.”
Greer Labs received FDA approval for the drug in April 2014. Oralair reduces grass allergy symptoms for patients within the first allergy season that it is administered, the company said. It is not indicated for the immediate relief of allergy symptoms.